Summary of Purpose
To discover outcomes of patients treated with Rivaroxaban with atrial fibrillation with at least one additional investigator-determined risk factor for stroke in real-life practice.Read More →
The following dates are available for this trial. Trial information last updated on 13 May 2015.
|1 May 2015||12 May 2015||1 Dec 2018||1 Dec 2018||1 May 2015||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Observation: Cohort
- Perspective: Prospective
- Sampling: Probability Sample